ergonovine has been researched along with Hyperlipoproteinemia Type II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McKinley, CA; Mousa, HA; Thong, J | 1 |
| Brock, J; Dalessandri, KM; Lantz, BM; Link, DP; Tsukamoto, H | 1 |
2 other study(ies) available for ergonovine and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Acute postpartum myocardial infarction after ergometrine administration in a woman with familial hypercholesterolaemia.
Topics: Adult; Contraindications; Ergonovine; Female; Humans; Hyperlipoproteinemia Type II; Myocardial Infarction; Oxytocics; Pregnancy; Puerperal Disorders | 2000 |
Superior mesenteric artery vasoactivity in hyperlipidemic Watanabe rabbits versus normal lipidemic New Zealand controls.
Topics: Animals; Blood Flow Velocity; Calcitonin Gene-Related Peptide; Ergonovine; Hyperlipoproteinemia Type II; Mesenteric Arteries; Rabbits; Serotonin; Vasoconstriction; Verapamil | 1989 |